Disclosed herein is a modular composition comprising 1) an oligonucleotide; 2) one or more tetraGalNAc ligands of Formula (I), which may be the same or different; optionally, 3) one or more linkers, which may be the same or different; and optionally, 4) one or more targeting ligands, solubilizing agents, pharmacokinetics enhancing agents, lipids, and/or masking agents.本發明揭示包含以下之模組化組合物:1)寡核苷酸;2)一或多個式(I)之四GalNAc配體,其可相同或不同;視情況,3)一或多個連接體,其可相同或不同;及視情況,4)一或多個靶向配體、增溶劑、藥物動力學增強劑、脂質及/或掩蔽劑。